APA (7th ed.) Citation

Laban, S., Remark, R., Idel, C., Ribbat-Idel, J., Krupar, R., Schröck, A., . . . Gnjatic, S. (2024). 915P Longer OS and RFS for CD3high/PD-L1+ head and neck squamous cell carcinoma (HNSCC) patients. Annals of Oncology, 35, S643. https://doi.org/10.1016/j.annonc.2024.08.976

Chicago Style (17th ed.) Citation

Laban, S., et al. "915P Longer OS and RFS for CD3high/PD-L1+ Head and Neck Squamous Cell Carcinoma (HNSCC) Patients." Annals of Oncology 35 (2024): S643. https://doi.org/10.1016/j.annonc.2024.08.976.

MLA (9th ed.) Citation

Laban, S., et al. "915P Longer OS and RFS for CD3high/PD-L1+ Head and Neck Squamous Cell Carcinoma (HNSCC) Patients." Annals of Oncology, vol. 35, 2024, p. S643, https://doi.org/10.1016/j.annonc.2024.08.976.